Innovative Awards: STEP Award


2004 (Cycle 10)

  Top
Her-2/neu-Crosreactive Analogs as Targets for Breast Cancer
Award: $371,110
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Apogossypol Derivatives for Breast Cancer Therapy
Award: $285,764
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Maspin: Breast Cancer Suppression through Enzyme Inhibition?
Award: $196,115
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Breast Cancer Chemoprevention with Dietary Herbal Estrogens
Award: $199,310
Institution: University of California, San Francisco Subject Area: Prevention & Risk Reduction

2003 (Cycle IX)

  Top
Studying the Interaction of an Essiac Tea and Food Mutagen
Award: $343,744
Institution: Lawrence Livermore National Laboratory Subject Area: Prevention & Risk Reduction
Novel I3C Regulated Cell Cycle Factor in Breast Cancer Cells
Award: $150,000
Institution: University of California, Berkeley Subject Area: Innovative Treatments
Inhibitors of Myc: Novel Drugs for Breast Cancer
Award: $277,887
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Angiogenesis in Hyperplasia to In-Situ Breast Cancers
Award: $250,000
Institution: University of California, Irvine Subject Area: Pathogenesis
Chinese Herb/Chemotherapy Interactions in Breast Cancer
Award: $200,000
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Functional Analysis of BORIS, A Novel DNA-binding Protein
Award: $92,426
Institution: Lawrence Berkeley National Laboratory Subject Area: Biology of the Normal Breast
Overcoming Tamoxifen-resistance in Breast Cancer
Award: $281,370
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Epstein-Barr Virus in Breast Cancer Tissues
Award: $275,260
Institution: Cancer Prevention Institute of California Subject Area: Etiology
Preventing Breast Cancer with Ginseng
Award: $99,708
Institution: University of California, Davis Subject Area: Prevention & Risk Reduction
Cryptic Peptides-Based Vaccines for Breast Tumor Treatment
Award: $371,110
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Dietary Indole Analogs Inhibit Breast Cancer Cell Invasion
Award: $381,491
Institution: SRI International Subject Area: Innovative Treatments
Early Transitions in Breast Cancer
Award: $199,424
Institution: University of California, San Francisco Subject Area: Biology of the Normal Breast
Late Cognitive and Brain Changes After Breast Cancer Therapy
Award: $250,000
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues

2002 (Cycle VIII)

  Top
Profiling Enzyme Activities in Models of Human Breast Cancer
Award: $369,508
Institution: Scripps Research Institute Subject Area: Pathogenesis
Fiber, Estrogen and Breast Cancer in Mexican American Women
Award: $159,117
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Cloning of the X Chromosome's Putative Tumor Suppressor Gene
Award: $284,375
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Steroid Receptor Coactivators in Mammary Gland Development
Award: $377,450
Institution: The Burnham Institute for Medical Research Subject Area: Biology of the Normal Breast
The Importance of Growth Inhibitory Signals in Normal Breast
Award: $150,000
Institution: University of California, Los Angeles Subject Area: Biology of the Normal Breast
Structure and Function of the Bax Apoptosis Regulator
Award: $285,141
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Retinoids in Combination Therapies against Breast Cancer
Award: $389,000
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Regulation of Estrogen Response by Corepressors
Award: $149,942
Institution: University of California, Davis Subject Area: Pathogenesis
Potential New Drug Therapy for Breast Cancer
Award: $199,740
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Identification and Prognostic Value of ERb in Breast Cancer
Award: $150,000
Institution: University of California, San Francisco Subject Area: Prevention & Risk Reduction
Identifying Accessible Targets in Human Breast Tumors
Award: $480,843
Institution: Sidney Kimmel Cancer Center Subject Area: Pathogenesis
The Detailed Structure of a Model Breast Cancer Genome
Award: $149,590
Institution: University of California, San Francisco Subject Area: Pathogenesis
PPAR Modulators as Apoptosis Sensitizers for Breast Cancer
Award: $456,924
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Three-Dimensional Modeling of Breast Cancer Progression
Award: $329,901
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy
Award: $378,972
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
TR3-based Peptides for Apoptosis in Breast Cancer
Award: $380,825
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Molecular Pathogenesis of Metastatic Breast Cancer
Award: $311,367
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Infinite Expansion of Breast Tumor Samples in Culture
Award: $311,400
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Immune-Function Genes and Race Differences in Breast Cancer
Award: $209,688
Institution: Cancer Prevention Institute of California Subject Area: Disparities

2001 (Cycle VII)

  Top
Role of Id-2 in Breast Cancer and its Relationship to Id-1
Award: $296,531
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Selective Targeting of Breast Cancer with Radioiodide
Award: $315,200
Institution: Stanford University Subject Area: Innovative Treatments
A New Genetic Vaccine Therapy for Breast Cancer
Award: $100,000
Institution: University of California, Irvine Subject Area: Innovative Treatments
Blood Vessel Markers in Breast Cancer
Award: $378,655
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Breast Cancer Imaging by 2-D Magnetic Resonance Spectroscopy
Award: $248,762
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
Overcoming Drug Resistance in Breast Cancer
Award: $378,529
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Early Detection of Breast Cancer and it Recurrence
Award: $365,446
Institution: Huntington Medical Research Institute Subject Area: Imaging, Biomarkers, & Molecular Pathology
Dietary Fat, Fat Metabolizing Genes and Breast Cancer Risk
Award: $383,740
Institution: University of Southern California Subject Area: Etiology
Clinical Utility of Breast Cancer DNA Markers in Serum
Award: $470,520
Institution: John Wayne Cancer Institute Subject Area: Imaging, Biomarkers, & Molecular Pathology
PPARd Ligands for Inhibition of Breast Cancer Progression
Award: $192,842
Institution: SRI International Subject Area: Innovative Treatments
In Vivo Effects of Chinese Herbal Extracts on Breast Cancer
Award: $199,600
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Targeting the EphB4 Receptor to Inhibit Breast Tumor Growth
Award: $184,576
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Herba Scutellaria Barbatae for Metastatic Breast Cancer
Award: $232,364
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Novel Inhibitors of Rad51-DNA Repair in Breast Cancer
Award: $130,332
Institution: Pangene Corporation Subject Area: Innovative Treatments